Post-transplant cyclophosphamide in haploidentical stem cell transplantation: evaluating the impact of transplant conditioning intensity
Our results suggest that TCI may reveal the role of chemoradiotherapy in promoting conditions that may contribute to the occurrence of GvHD. The impact of moderate/severe cGvHD on quality of life must challenge our efforts to further optimise prophylactic strategies.
Authors
- Maria Teresa Lupo Stanghellini (ORCID: https://orcid.org/0000-0003-1382-6939)
- Fabrizio Patriarca (ORCID: https://orcid.org/0000-0002-3840-492X)
- Raffaella Greco (ORCID: https://orcid.org/0000-0002-6117-5328)
- Marta Lisa Battista
- Fabio Ciceri
- Gabriele Facchin (ORCID: https://orcid.org/0000-0002-6695-8954)
- Umberto Pizzano (ORCID: https://orcid.org/0000-0002-2930-1136)
- Jacopo Peccatori (ORCID: https://orcid.org/0000-0003-4639-1716)
- Simona Piemontese (ORCID: https://orcid.org/0000-0002-5908-0792)
- Renato Fanin
Institutions
- University of Udine (IT)
- Vita-Salute San Raffaele University (IT)
- Ca' Foncello Hospital (IT)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-08-15
- DOI
- https://doi.org/10.3389/fimmu.2025.1610391
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00